Osrodek Badan Klinicznych Przy Szpitalu Specjalistycznym Im. Ludwika Rydygiera W Krakowie Sp. z o.o.

At Osrodek Badan Klinicznych Przy Szpitalu Specjalistycznym Im. Ludwika Rydygiera W Krakowie Sp. z o.o., clinical studies in musculoskeletal diseases focus on knee osteoarthritis and related chronic pain, with additional interest in weight-related joint burden. These trials are designed to test new symptom-relief options, improve daily function, and better understand treatment effectiveness for people living with long-term joint problems.

• knee osteoarthritis and chronic pain management
• overweight or obesity with joint symptoms
• Evaluating therapies that may reduce pain and improve mobility

The site’s work in this area reflects a practical focus on easing discomfort and supporting movement in patients with common, disabling musculoskeletal conditions.

Research in cardiovascular diseases includes atrial fibrillation, stroke prevention, hypertension, heart failure, and venous thromboembolism. These studies aim to improve protection against clot-related events, reduce bleeding risk, and assess treatments that may help patients with high cardiovascular risk or established heart disease.

• atrial fibrillation and prevention of cardioembolic events
• acute ischemic stroke and high-risk transient ischemic attack
• heart failure and hypertension management
• Balancing effectiveness with safer anticoagulation strategies

This portfolio shows a strong interest in better prevention and treatment approaches for major cardiovascular conditions that affect long-term health.

A large share of the research at this clinical research site centers on neoplasms, including breast cancer, lung cancer, head and neck cancer, prostate cancer, pancreatic cancer, bladder cancer, melanoma, and several types of lymphoma and leukemia. The trials mainly explore new therapies, combination treatments, and ways to improve survival or control disease after prior treatment.

• advanced or metastatic cancers across multiple tumor types
• lung cancer, breast cancer, and head and neck squamous cell carcinoma
• lymphoma and leukemia studies
• Testing targeted, immune-based, and combination cancer treatments

Overall, the oncology program is broad and active, with studies aimed at improving outcomes for both newly diagnosed and previously treated patients.

Clinical trials in nervous system diseases include multiple sclerosis, myasthenia gravis, spinal muscular atrophy, and stroke-related conditions. The research is focused on easing symptoms, slowing disability progression, and exploring more effective ways to prevent neurological injury or relapse.

• multiple sclerosis, including progressive and relapsing forms
• myasthenia gravis symptom control
• spinal muscular atrophy and treatment handling
• Improving prevention and recovery after stroke

These studies support a wider effort to refine care for chronic neurological disorders that can significantly affect independence and quality of life.

The site also participates in trials for digestive system diseases, especially colorectal cancer, Crohn-related fistula, and pancreatic disease, as well as post-surgical digestive problems such as pancreatic exocrine insufficiency and post-gastrectomy nutritional issues. These studies are intended to improve treatment response, symptom control, and nutritional support.

• colorectal cancer and pancreatic cancer
• Crohn’s disease-related fistula and bowel complications
• post-gastrectomy digestive and nutritional care
• Evaluating therapies that may improve digestion and overall patient support

This area combines cancer research with broader gastrointestinal care, reflecting a diverse set of digestive health priorities.

Studies in hemic and lymphatic diseases cover acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, multiple myeloma, and different forms of non-Hodgkin lymphoma and Hodgkin lymphoma. The main purpose is to assess new treatment combinations, improve remission rates, and support patients whose disease has returned or not responded to earlier therapy.

• leukemia and lymphoma treatment strategies
• multiple myeloma and immune support in blood cancers
• Trials for relapsed or refractory disease
• Testing therapies that may deepen response and extend disease control

The hematology program at the Krakow site is centered on improving care for complex blood cancers through innovative and comparative research.

Research in immune system diseases includes multiple sclerosis and other conditions where immune activity affects the nervous system or overall health. These trials aim to reduce disease activity, limit progression, and evaluate treatments that may offer better long-term control of immune-mediated illness.

• multiple sclerosis treatment and disability progression
• Immune-targeted approaches for chronic inflammatory disease
• Assessing whether newer options improve disease control

The research reflects a continued effort to refine therapies for patients with persistent immune-related conditions.

Trials in nutritional and metabolic diseases address obesity, cancer cachexia, and metabolic changes linked to chronic illness. The aim is to evaluate treatments that may help preserve body weight, support nutrition, and improve physical well-being in patients affected by cancer or heart disease.

• cancer cachexia and weight loss support
• obesity in patients with cardiovascular or joint disease
• Improving nutritional status and metabolic balance

These studies show an interest in the broader metabolic impact of serious illness, not just the primary diagnosis.

Some studies at the site span more than one specialty or address supportive care questions that do not fit neatly into a single category. These trials may focus on surgical bleeding management, infection prevention, or other practical clinical needs, with the goal of improving safety and everyday treatment outcomes.

• bleeding control and urgent procedure support
• Infection prevention in vulnerable patient groups
• Supportive and perioperative care research

Together, these projects add breadth to the site’s research profile and complement its disease-specific programs.